Ipamorelin powder is a peptide-selective agonist and growth hormone secretagogue of growth hormone releasing peptide/growth hormone secretagogue receptor (GHS). It is a pentapeptide with the amino acid sequence of Aib-His-D-2-Nal-D-Phe-Lys-NH2, derived from GHRP-1.
Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), which shows high GH release effect and efficacy in vitro and in vivo. As a result of a major chemical project, ipamorelin was found in a series of compounds lacking the central dipeptide Ala-Trp of growth hormone releasing peptide (GHRP) - 1. In vitro, ipamorelin released GH from primary rat pituitary cells, and its effect was similar to that of GHRP-6. Pharmacological analysis using GHRP and growth hormone releasing hormone (GHRH) antagonists clearly shows that iparilin/ipamorelin, like GHRP-6, stimulates GH release through GHRP-like receptors. Iparellin is a kind of drug substance, which can be used to stimulate the gastrointestinal system in the same way as Iparellin to stimulate the gastrointestinal system. We are ipamorelin supplement and we have ipamorelin for sale.
Our product
Product classification and COA:
Customized Bottle Caps & Corks
|
|
|
|
Chemical Formula |
C38H49N9O5 |
|
Exact Mass |
711.39 |
|
Molecular Weight |
711.87 |
|
m/z |
711.39 (100.0%), 712.39 (41.1%), 713.39 (5.5%), 712.38 (3.0%), 713.39 (2.7%), 713.39 (1.2%), 713.39 (1.0%) |
|
Elemental Analysis |
C, 64.12; H, 6.94; N, 17.71; O, 11.24 |
Ipamorelin powder, a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, is a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). Its experimental processes and results are often the focus of scientific research, but due to the specific nature of these studies, detailed experimental protocols and outcomes may not be widely available in a generalized form. However, I can provide an overview of the typical experimental approach and expected outcomes based on the current understanding of Ipamorelin research.
Experimental Process
Preparation
Synthesis
Ipamorelin is typically synthesized in a laboratory setting using solid-phase peptide synthesis or other advanced chemical methods. The synthesis process involves careful control of reaction conditions to ensure high purity and correct amino acid sequence.
Purification
The synthesized Ipamorelin is then purified to remove any impurities or by-products. This step is crucial for ensuring the biological activity and safety of the peptide.
In Vitro Experiments
Cell Culture
Experiments are conducted using cells that express the GHS-R, such as pituitary cells or cell lines derived from these tissues.
Stimulation Assays
Ipamorelin is added to the cultured cells at various concentrations, and the release of growth hormone (GH) is measured over time. This can be done using biochemical assays such as radioimmunoassay or ELISA.
Mechanism of Action Studies
Additional experiments may be performed to investigate the specific molecular mechanisms by which Ipamorelin stimulates GH release.
In Vivo Experiments
Animal Models
Ipamorelin is administered to animals (e.g., rodents) to study its effects on GH release and other physiological parameters.
Pharmacokinetics
The absorption, distribution, metabolism, and excretion (ADME) of Ipamorelin are studied to understand its behavior in the body.
Efficacy and Safety
The therapeutic potential and safety profile of Ipamorelin are evaluated in animal models of various diseases or conditions.
 |
 |
Expected Results
In Vitro
GH Release
Ipamorelin is expected to stimulate the release of GH from cultured cells in a dose-dependent manner.
Mechanism of Action
Studies may reveal that Ipamorelin binds to the GHS-R and triggers a signaling cascade leading to GH release.
In Vivo
Pharmacodynamics
Ipamrelin is expected to increase serum GH levels in animals, with a dose-response relationship observed.
Efficacy
Depending on the specific experimental model, Ipamrelin may demonstrate beneficial effects on muscle growth, bone density, or other physiological parameters.
Safety
Ipamrelin should be well-tolerated with minimal adverse effects at therapeutic doses. However, careful monitoring for potential side effects is essential.
Important Considerations
Experimental Design
The design of Ipamorelin experiments must be rigorous and controlled to ensure the validity and reproducibility of results.
Ethics
Animal experiments must be conducted in accordance with ethical guidelines and regulations to minimize suffering and ensure animal welfare.
Translational Relevance
While preclinical studies are essential for understanding the mechanisms of action and potential therapeutic effects of Ipamrelin, the translation of these findings to human patients requires further clinical research.
Conclusion
The experimental processes and results of Ipamrelin research are complex and multifaceted, involving both in vitro and in vivo studies. While a detailed description of specific experimental protocols and outcomes is beyond the scope of this response, the general approach and expected results have been outlined based on the current understanding of Ipamrelin research.
Ipamorelin powder, also known as a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R), has a wide range of potential applications, particularly in the field of medicine and health research. However, it's important to note that the specific applications of Ipamorelin can vary and are often under ongoing investigation. Below is a detailed introduction to its potential uses based on current understanding:
Growth Hormone Stimulation
- Mechanism of Action: Ipamrelin acts as a growth hormone secretagogue, stimulating the release of growth hormone (GH) from the anterior pituitary gland. This is achieved by binding to the GHS-R, which is expressed in the pituitary and hypothalamus.
- Potential Benefits: By increasing GH levels, Ipamrelin may have beneficial effects on muscle growth, bone density, and overall body composition. It is therefore being explored for its potential in sports medicine, anti-aging therapies, and the treatment of growth hormone deficiencies.
Clinical Research
- Ongoing Studies: While Ipamrelin has shown promise in preclinical studies, its clinical applications are still being investigated. Researchers are exploring its efficacy and safety in treating various conditions, including growth hormone deficiencies, cachexia (muscle wasting), and potentially even obesity and diabetes.
- Collaboration: Pharmaceutical companies and research institutions are actively collaborating to conduct clinical trials and evaluate the potential of Ipamrelin in various therapeutic areas.
Pharmaceutical Use
- Formulations: Ipamrelin is typically administered as a peptide, which can be formulated in various ways to ensure optimal bioavailability and stability.
- Dosage and Administration: The dosage and administration schedule of Ipamrelin will depend on the specific condition being treated and the patient's individual characteristics.
1. Regulatory Status
- Approval Status: The regulatory status of Ipamrelin may vary depending on the jurisdiction. In some countries, it may be approved for specific indications, while in others, it may still be under investigation.
- Safety and Efficacy: Regulatory agencies will require rigorous safety and efficacy data before approving Ipamrelin for clinical use.
2. Precautions and Side Effects
- Precautions: As with any medication, patients should be carefully screened for potential contraindications before starting treatment with Ipamrelin.
- Side Effects: Common side effects may include nausea, headache, and fatigue. More severe side effects are possible but less common.
3. Future Directions
- Continued Research: As research on Ipamrelin progresses, we can expect to see a better understanding of its mechanisms of action, potential therapeutic applications, and long-term safety profile.
- Innovative Formulations: Researchers may also develop innovative formulations and delivery systems to improve the bioavailability and stability of Ipamrelin.
In summary, Ipamorelin powder is a promising peptide with potential applications in various therapeutic areas. However, its specific uses and efficacy will depend on ongoing clinical research and regulatory approvals. It's important to consult with a healthcare professional before considering Ipamrelin for any medical condition.
The chemical synthesis of Ipamrelin mainly adopts solid-phase peptide synthesis technology. The following are the detailed synthesis steps and key points:
Raw materials: involving various amino acids, such as Nalpha-FMOC-Nepsilon-Boc-L-lysine,FMOC-D-phenylalanine,FMOC-D-2-naphthylalanine,FMOC-Npi-trityl-L-histidine Wait, and 2- (tert butoxycarbonylamino) isobutyric acid.
Starting carrier: Fluoranylmethoxycarbonyl Rink amide resin and other resins are used as starting carriers to provide a foundation for subsequent amino acid coupling.
Step 1: The resin is coupled with Nalpha-FMOC-Nopsilon-Boc-L-lysine, which is the initial step in constructing peptide chains. Amino acids are connected to the resin carrier through chemical reactions.
Subsequent steps: Add amino acids such as FMOC-D-phenylalanine, FMOC-D-2-naphthalanine, and FMOC-Npi-trityl-L-histidine in sequence for coupling. The coupling of each amino acid requires deprotection of the Fmoc group, which exposes the active site of the amino acid for coupling reaction with the next amino acid. Then, new amino acids are added for coupling, gradually extending the peptide chain.
Final coupling: After completing the coupling of all amino acids, 2- (tert butoxycarbonylamino) isobutyric acid is added for final coupling, which further improves the structure of the peptide chain.
Cutting: Treat the resin with trifluoroacetic acid to eliminate Boc protecting groups and cut the target peptide chain from the resin. Trifluoroacetic acid is a strong acid that can break the bond between resin and peptide chain, while removing the Boc protecting group to restore the activity of the peptide chain.
Purification: The cut peptide chain undergoes purification treatment to remove impurities. Purification methods typically use techniques such as chromatographic separation to separate peptide chains from impurities based on their physical and chemical properties, resulting in high-purity Ipamrelin.
Drying: The purified peptide chain is dried to obtain Ipamorelin powder. The drying process can remove moisture from peptide chains, improve their stability and shelf life.
Synthesis conditions: The entire synthesis process needs to be carried out under suitable environment and conditions, such as temperature, pH value, reaction time, etc., which need to be strictly controlled to ensure the smooth progress of the reaction and the quality of the product.
Operating procedures: Relevant operating procedures need to be followed during the production process, such as the order of reagent addition, cleaning and disinfection of reaction containers, etc., to avoid contamination and cross reactions, and ensure the purity and quality of the product.
Patent technology: The specific synthesis path belongs to patent technology, and some details may be protected by intellectual property rights. In practical applications, relevant laws and regulations need to be followed.
Hot Tags: Ipamorelin Powder CAS 170851-70-4, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, DERMORPHIN, dermorphin peptide, dermorphin in humans, Melanotan ii powder, Cosmetic